Monogram gains FDA clearance for its robotic-assisted knee surgery system and plans clinical trials in India to expand ...

From new clearances and debuts, here are five key headlines in orthopedic robotics during the first quarter of 2025. 1. Stryker’s Mako shoulder robot earned FDA approval in December, according to a ...

On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies ... commercializing the mBôs TKA System as capital efficiently as possible.

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

Meet the Mets: endearing, entertaining ... and eternal underdogs. But the franchise vibes are changing thanks to a ...

A new Starbucks Reserve and pickleball academy are just two of the businesses residents can look forward to in the Lake ...

Choose from Capital K stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials collection ...

Monogram Orthopaedics, Inc. (NASDAQ:MGRM – Free Report) – Stock analysts at Roth Capital upped their FY2028 earnings per share (EPS) estimates for Monogram Orthopaedics in a research report ...

MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...

Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).